SEC Form 4 Reporting Owner · CIK 0001920574
Orbimed Capital Gp IX LLC
Director at Windward BIO Group Ag · Director at Braveheart Bio Inc · Director at Shattuck Labs Inc · +1 more
Bought (12 mo)
+$54.9M
Sold (12 mo)
—
Form 4 Filings
6
Companies
4
Filing Activity
2026-11-18
first filed 2024-11-05
Trading record
Open-market buys
+$60.4M
4 filings
Open-market sales
—
0 filings
Sales under a 10b5-1 plan
—
No open-market sales
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| WWBWindward BIO Group Ag Insider trading | Director | 1 | 1,176,471 | — | +1,176,471 | 7,097,715 2026-11-18 |
| BRVEBraveheart Bio Insider trading | Director | 1 | 1,940,000 | — | +1,940,000 | 11,901,826 2026-08-11 |
| STTKShattuck Labs Insider trading | Director | 3 | 6,306,127 | — | +6,306,127 | 6,306,127 2026-06-15 |
| Lomond Therapeutics Insider trading | Director | 1 | — | — | — | 2,677,256 2024-11-05 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.